Medis Product Portfolio

Filters

Therapeutic Area

Toggle

Dosage Form

Toggle

Showing 10 of 15 results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

Ascorbic Acid

Status:
Available
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
100mg/ml (2ml, 5ml, 10ml)
Dosage Form:
Oral Solution, Stick Packs
Availability:
Available

Budesonide

Status:
Available
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
3mg
Dosage Form:
Capsule, Gastro Resistant
Availability:
Available

Canagliflozin

Status:
Under development
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
100mg, 300mg
Dosage Form:
Film-Coated Tablet
Availability:
Under development

Dapagliflozin

Status:
Available
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
5mg, 10mg
Dosage Form:
Film-Coated Tablet
Availability:
Available

Gliclazide

Status:
Available
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
30mg, 60mg
Dosage Form:
Modified Release Tablet
Availability:
Available

Granisetron

Status:
Available
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
1mg, 2mg
Dosage Form:
Film-Coated Tablet
Availability:
Available

Lansoprazole

Status:
Available
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
15mg, 30mg
Dosage Form:
Gastro-resistant Capsule
Availability:
Available

Linagliptin

Status:
Under development
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
5mg
Dosage Form:
Film-Coated Tablet
Availability:
Under development

Metformin

Status:
Under development
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
500mg, 750mg, 1000mg
Dosage Form:
Extended Release Tablet
Availability:
Under development

Obeticholic Acid

Status:
Under development
Therapeutic Area:
Alimentary Tract and Metabolism
Dosage:
5mg, 10mg
Dosage Form:
Film-Coated Tablet
Availability:
Under development

IP Disclaimer: Not all the products are available for all territories. Please check availability with Medis business development.